Management of the kidney transplant recipient

Primary Care
Aparna PadiyarD E Hricik

Abstract

The short-term outcomes of kidney transplant recipients have improved dramatically in the past 20 years, in large part resulting from the availability of more potent immunosuppressive drugs capable of preventing or treating acute allograft rejection. Ironically, side effects from these same immunosuppressants play a role in the long-term morbidity and mortality of this patient population. As kidney transplant recipients survive for longer periods of time with functioning allografts, primary care physicians will likely become more involved in their management, mandating at least a basic understanding of immunosuppression and its complications.

References

Mar 1, 1988·Transplantation·C ToussaintP Vereerstraeten
Jan 1, 1996·Journal of the American Society of Nephrology : JASN·B L KasiskeJ Z Ma
Jun 12, 1998·The New England Journal of Medicine·J A Fishman, R H Rubin
Nov 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R N FoleyM J Sarnak
Jul 18, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Conrad B Blum
Mar 26, 2004·Transplantation Proceedings·B D Kahan
Mar 26, 2004·Transplantation Proceedings·J J Augustine, D E Hricik
May 19, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Bertram L KasiskeChangchun Wang
Jun 18, 2004·Transplantation·John J Fung
Oct 2, 2004·Kidney International·Bengt FellströmUNKNOWN Assessment of Lescol in Renal Transplantation Study Investigators
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Camille Nelson KottonJay A Fishman
Feb 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nina Singh
Apr 5, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Suetonia C PalmerDavid O McGregor
Sep 1, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Alan G JardineHallvard Holdaas
Oct 28, 2005·Transplantation·Gaetano CiancioThomas A Gonwa
Dec 8, 2005·JAMA : the Journal of the American Medical Association·Robert M MerionFriedrich K Port
Jan 10, 2006·Seminars in Dialysis·Kevin J O'Connor, Francis L Delmonico
Apr 15, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H-U Meier-KriescheA B Leichtman
Jul 11, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·H Myron KauffmanDouglas W Hanto
Sep 14, 2006·Transplantation·Allan D Kirk
Nov 11, 2006·Current Opinion in Lipidology·Riza C OzsoyMarion G Koopman
Dec 21, 2006·JAMA : the Journal of the American Medical Association·Claire M VajdicAndrew E Grulich
Mar 3, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·P J VilleneuveY Mao
Apr 25, 2007·Transplantation·Thomas E BurroughsMark A Schnitzler
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Alan Wilkinson
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Arjang DjamaliBryan N Becker
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Joshua J Augustine, Donald E Hricik
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·José R WeisingerEzequiel Bellorin-Font
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Michael F Crutchlow, Roy D Bloom
Nov 7, 2007·Endocrinology and Metabolism Clinics of North America·Neveen A T Hamdy
Nov 21, 2007·Cleveland Clinic Journal of Medicine·Aparna Padiyar, Mahboob Rahman

❮ Previous
Next ❯

Citations

Apr 28, 2010·Journal of General Internal Medicine·Gaurav GuptaPeggy B Hasley
May 27, 2010·The Journal of Clinical Investigation·Pervinder SagooRobert I Lechler
May 24, 2014·International Journal of Clinical Practice·R F CastilloI García García
Oct 11, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G S LeeP L Abt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis